Lung Cancer Clinical Trials with a Seamless Phase II/III Design: Systematic Review

Current lung cancer clinical research focuses on biomarkers and personalized treatment strategies. Adaptive clinical trial designs have gained significant ground due to their increased flexibility, compared to the conventional model of drug development from phase I to phase IV trials. One such adapt...

Descripción completa

Detalles Bibliográficos
Autores principales: Palermos, Dionysios, Sergentanis, Theodoros N., Gavriatopoulou, Maria, Malandrakis, Panagiotis, Psaltopoulou, Theodora, Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739886/
https://www.ncbi.nlm.nih.gov/pubmed/36498749
http://dx.doi.org/10.3390/jcm11237176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739886/
https://www.ncbi.nlm.nih.gov/pubmed/36498749
http://dx.doi.org/10.3390/jcm11237176

Ejemplares similares